Cryo-Cell IntlCCEL
13F holders, Q3 2024 (September 30)14holders
2new positions
2sold out
$6.37avg. 13F price*
At the end of Q3 2024, 14 institutions reported holding Cryo-Cell Intl Inc. (CCEL) in their 13F filings, unchanged from Q2 2024. 2 opened new positions and 2 sold out. The largest holders were Hamilton Lane Advisors LLC ($2.6M), SFI Advisors, LLC ($1.1M) and Vanguard Group Inc. ($744K).
- Company
- Cryo-Cell Intl Inc.
- CUSIP
- 228895108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $6K |
| Exits | 2 | $111K |
All 13F filers, Q2 2024 → Q3 2024: 19,140 shares bought and 14,941 shares sold, net +4,199 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 14 holders
| Hamilton Lane Advisors LLC | 2.26% | No change | 409,734 | $2.6M |
| SFI Advisors, LLC | 0.75% | No change | 165,300 | $1.1M |
| Vanguard Group Inc. | 0.00% | Add +1.8% | 116,848 | $744K |
| MassMutual Private Wealth & Trust, FSB | 0.02% | No change | 111,035 | $707K |
| Geode Capital Management, LLC | 0.00% | Add +68.5% | 39,860 | $254K |
| Northern Trust Corp. | 0.00% | Reduce -1.6% | 21,836 | $139K |
| Cerity Partners LLC | 0.00% | No change | 19,563 | $125K |
| BlackRock, Inc. | 0.00% | — | 13,657 | $87K |
| Osaic Holdings, Inc. | 0.00% | No change | 2,000 | $13K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 619 | $4K |
| Morgan Stanley | 0.00% | Reduce -0.2% | 600 | $4K |
| UBS Group AG | 0.00% | New | 249 | $2K |
| Bank of America Corp. | 0.00% | Reduce -42.1% | 33 | $210 |
| JPMorgan Chase & Co. | 0.00% | No change | 11 | $70 |
"% of holder's portfolio" is CCEL's weight in each manager's 13F, not the share of Cryo-Cell Intl Inc. the manager owns.